Cargando…
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Duchenne muscular dystrophy (DMD) is a lethal, X-linked disease that causes severe loss of muscle mass and function in young children. Promising therapies for DMD are being developed, but the long lead times required when using clinical outcome measures are hindering progress. This progress would be...
Autores principales: | Grounds, Miranda D., Terrill, Jessica R., Al-Mshhdani, Basma A., Duong, Marisa N., Radley-Crabb, Hannah G., Arthur, Peter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063669/ https://www.ncbi.nlm.nih.gov/pubmed/32224496 http://dx.doi.org/10.1242/dmm.043638 |
Ejemplares similares
-
A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
por: Al-Mshhdani, Basma A., et al.
Publicado: (2021) -
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2020) -
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2016) -
Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
por: Radley-Crabb, Hannah G., et al.
Publicado: (2014) -
Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy
por: Grounds, Miranda D., et al.
Publicado: (2023)